In a recent investigation on this group, among 8 biomarkers representing distinct biological pathways to the incidence of MS only plasminogen activator inhibitor-1 (PAI-1) and aldosterone were significantly associated with the incidence of metabolic syndrome, relations that remained robust after adjustment for insulin resistance (HOMA-IR). The gene discussed is SERPINE1; the disease is myeloid sarcoma.